Training for mental health professionals in responding to experienced and anticipated mental health-related discrimination (READ-MH): protocol for an international multisite feasibility study.

Discrimination Health advocacy Health professionals Mental health care Objective structured Clinical examination Stigma Training

Journal

Pilot and feasibility studies
ISSN: 2055-5784
Titre abrégé: Pilot Feasibility Stud
Pays: England
ID NLM: 101676536

Informations de publication

Date de publication:
13 Dec 2022
Historique:
received: 18 03 2022
accepted: 13 10 2022
entrez: 13 12 2022
pubmed: 14 12 2022
medline: 14 12 2022
Statut: epublish

Résumé

Mental health and other health professionals working in mental health care may contribute to the experiences of stigma and discrimination among mental health service users but can also help reduce the impact of stigma on service users. However, few studies of interventions to equip such professionals to be anti-stigma agents took place in high-income countries. This study assesses the feasibility, potential effectiveness and costs of Responding to Experienced and Anticipated Discrimination training for health professionals working in mental health care (READ-MH) across low- and middle-income countries (LMICs). This is an uncontrolled pre-post mixed methods feasibility study of READ-MH training at seven sites across five LMICs (China, Ethiopia, India, Nepal and Tunisia). knowledge based on course content, attitudes to working to address the impact of stigma on service users and skills in responding constructively to service users' reports of discrimination. The training draws upon the evidence bases for stigma reduction, health advocacy and medical education and is tailored to sites through situational analyses. Its content, delivery methods and intensity were agreed upon through a consensus exercise with site research teams. READ-MH will be delivered to health professionals working in mental health care immediately after baseline data collection; outcome measures will be collected post-training and 3 months post-baseline, followed by qualitative data collection analysed using a combined deductive and inductive approach. Fidelity will be rated during the delivery of READ-MH, and data on training costs will be collected. Quantitative data will be assessed using generalised linear mixed models. Qualitative data will be evaluated by thematic analysis to identify feedback about the training methods and content, including the implementability of the knowledge and skills learned. Pooled and site-specific training costs per trainee and per session will be reported. The training development used a participatory and contextualised approach. Evaluation design strengths include the diversity of settings, the use of mixed methods, the use of a skills-based measure and the knowledge and attitude measures aligned to the target population and training. Limitations are the uncertain generalisability of skills performance to routine care and the impact of COVID-19 restrictions at several sites limiting qualitative data collection for situational analyses.

Sections du résumé

BACKGROUND BACKGROUND
Mental health and other health professionals working in mental health care may contribute to the experiences of stigma and discrimination among mental health service users but can also help reduce the impact of stigma on service users. However, few studies of interventions to equip such professionals to be anti-stigma agents took place in high-income countries. This study assesses the feasibility, potential effectiveness and costs of Responding to Experienced and Anticipated Discrimination training for health professionals working in mental health care (READ-MH) across low- and middle-income countries (LMICs).
METHODS METHODS
This is an uncontrolled pre-post mixed methods feasibility study of READ-MH training at seven sites across five LMICs (China, Ethiopia, India, Nepal and Tunisia).
OUTCOME MEASURES METHODS
knowledge based on course content, attitudes to working to address the impact of stigma on service users and skills in responding constructively to service users' reports of discrimination. The training draws upon the evidence bases for stigma reduction, health advocacy and medical education and is tailored to sites through situational analyses. Its content, delivery methods and intensity were agreed upon through a consensus exercise with site research teams. READ-MH will be delivered to health professionals working in mental health care immediately after baseline data collection; outcome measures will be collected post-training and 3 months post-baseline, followed by qualitative data collection analysed using a combined deductive and inductive approach. Fidelity will be rated during the delivery of READ-MH, and data on training costs will be collected. Quantitative data will be assessed using generalised linear mixed models. Qualitative data will be evaluated by thematic analysis to identify feedback about the training methods and content, including the implementability of the knowledge and skills learned. Pooled and site-specific training costs per trainee and per session will be reported.
CONCLUSIONS CONCLUSIONS
The training development used a participatory and contextualised approach. Evaluation design strengths include the diversity of settings, the use of mixed methods, the use of a skills-based measure and the knowledge and attitude measures aligned to the target population and training. Limitations are the uncertain generalisability of skills performance to routine care and the impact of COVID-19 restrictions at several sites limiting qualitative data collection for situational analyses.

Identifiants

pubmed: 36514144
doi: 10.1186/s40814-022-01208-8
pii: 10.1186/s40814-022-01208-8
pmc: PMC9745687
doi:

Types de publication

Journal Article

Langues

eng

Pagination

257

Subventions

Organisme : Medical Research Council
ID : MR/S001255/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/S023224/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/R023697/1
Pays : United Kingdom

Commentaires et corrections

Type : UpdateOf

Informations de copyright

© 2022. The Author(s).

Références

Br J Psychiatry. 2015 Nov;207(5):377-84
pubmed: 26527664
Br J Addict. 1987 Jul;82(7):753-9
pubmed: 3478065
Lancet Psychiatry. 2014 Nov;1(6):467-82
pubmed: 26361202
Behav Res Ther. 2015 Jun;69:11-21
pubmed: 25847276
BMJ. 2014 Mar 07;348:g1687
pubmed: 24609605
J Adv Nurs. 2012 Jun;68(6):1359-68
pubmed: 21981761
Int J Soc Psychiatry. 2008 Sep;54(5):469-78
pubmed: 18786908
Aust N Z J Psychiatry. 2014 Apr;48(4):360-70
pubmed: 24253359
Psychiatr Serv. 2011 Dec;62(12):1470-6
pubmed: 22193795
Soc Psychiatry Psychiatr Epidemiol. 2022 Sep;57(9):1861-1873
pubmed: 35451604
BMC Med Educ. 2019 Jan 31;19(1):41
pubmed: 30704531
Community Pract. 2007 Sep;80(9):26-9
pubmed: 17900024
Soc Sci Med. 2020 Jun;255:112974
pubmed: 32388323
World Psychiatry. 2012 Feb;11(1):61
pubmed: 22295014
Med Teach. 2013 Sep;35(9):e1437-46
pubmed: 23968323
Psychiatr Serv. 2014 Nov 1;65(11):1360-6
pubmed: 25081996
Fortschr Neurol Psychiatr. 2014 Oct;82(10):586-92
pubmed: 25299630
Lancet. 2016 Mar 12;387(10023):1123-1132
pubmed: 26410341
Acta Psychiatr Scand. 2016 Aug;134 Suppl 446:14-22
pubmed: 27426642
Aust N Z J Psychiatry. 1999 Feb;33(1):77-83
pubmed: 10197888
Pilot Feasibility Stud. 2018 Jan 24;4:36
pubmed: 29403650
Asian J Psychiatr. 2022 Jul;73:103096
pubmed: 35430494
Psychiatry Res. 2018 Jan;259:526-531
pubmed: 29156425
Lancet. 1998 Sep 26;352(9133):1058-9
pubmed: 9759771
Eur Psychiatry. 2004 Nov;19(7):423-7
pubmed: 15504649
Int J Soc Psychiatry. 2004 Dec;50(4):319-30
pubmed: 15648745
Acad Psychiatry. 2010 Nov-Dec;34(6):424-32
pubmed: 21041465
Fam Syst Health. 2018 Jun;36(2):198-209
pubmed: 29902036
Lancet. 2007 Sep 8;370(9590):878-89
pubmed: 17804062
Community Ment Health J. 2021 Jul;57(5):985-993
pubmed: 32892303
Pilot Feasibility Stud. 2022 Jan 14;8(1):5
pubmed: 35031066
Int J Ment Health Syst. 2019 Jan 03;13:1
pubmed: 30622627
Int Rev Psychiatry. 2007 Apr;19(2):137-55
pubmed: 17464792
Int J Environ Res Public Health. 2021 Feb 22;18(4):
pubmed: 33671743
Acad Psychiatry. 2016 Apr;40(2):339-47
pubmed: 26162463
Acta Psychiatr Scand Suppl. 2006;(429):51-9
pubmed: 16445483

Auteurs

Claire Henderson (C)

Centre for Implementation Science, Health Services and Population Research Department, Institute of Psychiatry, Psychology and Neuroscience, King's College London, De Crespigny Park Box, London, SE5 8AF, UK. claire.1.henderson@kcl.ac.uk.
South London and Maudsley NHS Foundation Trust, Denmark Hill, London, SE5 8AZ, UK. claire.1.henderson@kcl.ac.uk.

Uta Ouali (U)

Department Psychiatry A, Razi University Hospital, Cité des Orangers, 2010, La Manouba, Tunisia.

Ioannis Bakolis (I)

Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.

Nada Berbeche (N)

Department of Psychology, Laboratory of Clinical Psychology: Intersubjectivity and Culture, University of Tunis, Tunis, Tunisia.

Kalpana Bhattarai (K)

Transcultural Psychosocial Organization (TPO), Kathmandu, Nepal.

Elaine Brohan (E)

Centre for Global Mental Health, Health Services and Population Research Department, Institute of Psychiatry, Psychology and Neuroscience, King's College London, De Crespigny Park, London, SE5 8AF, UK.

Anish Cherian (A)

National Institute of Mental Health and Neurosciences (NIMHANS), Bengaluru, India.

Eshetu Girma (E)

Department of Preventive Medicine, School of Public Health, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.

Petra C Gronholm (PC)

Centre for Global Mental Health and Centre for Implementation Science, Health Service and Population Research Department, Institute of Psychiatry, Psychology and Neuroscience, King's College London, De Crespigny Park Box, London, SE5 8AF, UK.

Dristy Gurung (D)

Transcultural Psychosocial Organization (TPO), Kathmandu, Nepal.

Charlotte Hanlon (C)

Centre for Global Mental Health, Health Services and Population Research Department, Institute of Psychiatry, Psychology and Neuroscience, King's College London, De Crespigny Park, London, SE5 8AF, UK.
Department of Psychiatry, WHO Collaborating Centre for Mental Health Research and Capacity-building, School of Medicine, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.

Sudha Kallakuri (S)

George Institute for Global Health, 308 Elegance Tower, New Delhi, 110025, India.

Amanpreet Kaur (A)

George Institute for Global Health, 308 Elegance Tower, New Delhi, 110025, India.

Bezawit Ketema (B)

Department of Preventive Medicine, School of Public Health, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.

Heidi Lempp (H)

Centre for Rheumatic Diseases, Department of Inflammation Biology, School of Immunology and Microbial Sciences, Faculty of Life Sciences & Medicine, Weston Education Centre, 10, Cutcombe Rd, London, SE5 9RJ, UK.

Jie Li (J)

The Affiliated Brain Hospital of Guangzhou Medical University, No. 36 Mingxin Road, Liwan District, Guangzhou, 510370, China.

Santosh Loganathan (S)

National Institute of Mental Health and Neurosciences (NIMHANS), Bengaluru, India.

Pallab K Maulik (PK)

George Institute for Global Health, 308 Elegance Tower, New Delhi, 110025, India.
Faculty of Medicine, University of New South Wales, Sydney, Australia.

Gurucharan Mendon (G)

National Institute of Mental Health and Neurosciences (NIMHANS), Bengaluru, India.

Tesfahun Mulatu (T)

Department of Preventive Medicine, School of Public Health, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.

Ning Ma (N)

Peking University Sixth Hospital (Institute of Mental Health), National Clinical Research Center for Mental Disorders & Key Laboratory of Mental Health, Ministry of Health (Peking University, No 51, Huayuanbei Road, Haidian District, Beijing, 100191, China.

Renee Romeo (R)

King's Health Economics, Health Service and Population Research Department, Institute of Psychiatry, Psychology and Neuroscience, King's College London, De Crespigny Park Box, London, SE5 8AF, UK.

Rahul Kodihalli Venkatesh (RK)

National Institute of Mental Health and Neurosciences (NIMHANS), Bengaluru, India.

Yosra Zgueb (Y)

Faculty of Medicine of Tunis, University of Tunis El Manar, Tunis, Tunisia.

Wufang Zhang (W)

Peking University Sixth Hospital (Institute of Mental Health), National Clinical Research Center for Mental Disorders & Key Laboratory of Mental Health, Ministry of Health (Peking University, No 51, Huayuanbei Road, Haidian District, Beijing, 100191, China.

Graham Thornicroft (G)

Centre for Global Mental Health and Centre for Implementation Science, Health Service and Population Research Department, Institute of Psychiatry, Psychology and Neuroscience, King's College London, De Crespigny Park Box, London, SE5 8AF, UK.

Classifications MeSH